Assessing DocuSign (DOCU) Valuation After Iris AI Assistant Expands Intelligent Agreement Management Capabilities

DocuSign (DOCU) stock is back in focus after the company used its Momentum conference to showcase Iris, a new AI engine that sits at the center of its Intelligent Agreement Management platform.

See our latest analysis for DocuSign.

Despite the product buzz around Iris and Intelligent Agreement Management, the stock has been under pressure, with the share price at US$48.43, a year-to-date share price decline of 25.32%, and a 1-year total shareholder return decline of 43.57%. However, the 30-day share price return of 6.07% hints at tentative momentum rebuilding in the shorter term.

If DocuSign's AI push has your attention, it can be useful to look across the sector and compare with other potential beneficiaries through 64 profitable AI stocks that aren't just burning cash

With DocuSign trading at US$48.43, a value score of 3, and an implied discount to its average analyst price target, the key question is whether markets are underestimating Iris-driven growth or have already priced it in.

Most Popular Narrative: 20% Undervalued

At a last close of $48.43 versus a narrative fair value of $60.16, the current price sits below what this widely followed framework considers reasonable, with that view built on detailed forecasts for revenue, margins, and future earnings multiples.

Rollout and ramp-up of the IAM platform, with AI-native features and deep enterprise system integrations, is unlocking significant upsell opportunities as customers migrate from core eSignature to broader agreement management, driving improved ARPU and supporting double-digit future topline growth.

Read the complete narrative.

Curious what sits behind that fair value gap? The narrative focuses on steady top line expansion, fatter profit margins, and a future earnings multiple that assumes meaningful scale effects without stretching into blue sky territory.

Result: Fair Value of $60.16 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are clear watchpoints, including signs of maturing eSignature demand and intensifying competition that could pressure DocuSign's pricing power and long term margin ambitions.

Find out about the key risks to this DocuSign narrative.

Another View: Market Multiple Sends a Different Signal

While the narrative fair value of $60.16 points to an undervalued stock, the current P/E of 30.4x is slightly above the fair ratio of 29.2x and also a touch higher than the US Software industry at 30x, suggesting less margin for error than the story implies. Which signal do you trust more when risk is front of mind?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

The mix of pressure on the stock and optimism around Iris makes this a good moment to review the facts yourself and move quickly to shape your own view by using the full breakdown of 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If DocuSign has sharpened your thinking, do not stop here. Use powerful screeners to uncover other stocks that better match your style and goals.

• Target resilient cash generators with strong fundamentals by checking the solid balance sheet and fundamentals stocks screener (46 results).
• Hunt for potential bargains that pair quality with attractive pricing through the 46 high quality undervalued stocks.
• Prioritize consistency and stability in your portfolio by reviewing the 64 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com